Urticaria and Angioedema: an Update on Classification and Pathogenesis

Area of Science:

• Immunology
• Dermatology
• Allergy

Background:

• Urticaria is a prevalent mast cell-mediated disorder characterized by wheals and/or angioedema.
• Despite clinical classification consensus, the underlying pathogenesis of urticaria remains incompletely understood.
• Recent research and omalizumab's approval have heightened clinical and research interest in urticaria.

Purpose of the Study:

• To review current urticaria management guidelines.
• To present novel insights into urticaria pathogenesis, particularly chronic spontaneous urticaria (CSU) and chronic inducible urticaria (CIndU).
• To discuss the impact of these advancements on clinical practice.

Main Methods:

• Literature review of current urticaria management guidelines.
• Synthesis of recent research on urticaria pathogenesis, including cellular and molecular mechanisms.
• Analysis of autoimmune processes in CSU and mast cell activation pathways.

Main Results:

• Urticaria is classified clinically into acute and chronic forms (CSU and CIndU).
• Key research areas include mast cell activation mechanisms and autoimmune contributions to CSU.
• Non-sedating antihistamines and omalizumab are current first-line therapies for chronic urticaria.

Conclusions:

• Current management of chronic urticaria relies on non-sedating antihistamines and omalizumab.
• Understanding pathogenesis is crucial for developing novel targeted therapies.
• Future strategies aim to specifically target pathogenic cells and mediators in urticaria.